The observed high levels of IL-6 and its circulating receptor have been responsible for the deleterious effects on the liver sinusoidal endothelial cells, and blood clotting, and for contributing to liver injury in COVID-19 patients (McConnell et al., 2021). The gene discussed is IL6; the disease is COVID-19.